Skip to main content

ORAL MONOVALENT TYPE 2 POLIOMYELITIS VACCINE (mOPV2)

Product overview

Vaccine type
Polio Vaccine - Oral (OPV) Monovalent Type 2
Commercial Name
ORAL MONOVALENT TYPE 2 POLIOMYELITIS VACCINE (mOPV2)
Manofacturer
Sanofi Pasteur
Responsible NRA
Agence nationale de sécurité du médicament et des produits de santé
Country
France

Prequalification

Prequalification Status
Current
Effective Date

Product description

Pharmaceutical Form
Liquid: ready to use
Presentation
Vial
Number of Doses
20
Diluent
Not Applicable
Route of Administration
Oral
Shelf Life
60 months
Storage Temperature
-20°C
Vaccine Vial Monitor
Type 2
Secondary Packaging
Carton of 10 vials [Dimensions: 7.3 x 2.9 x 4.6 cm]
Tertiary Packaging
Insulated box of 440 packs of 10 vial cartons (88,000 doses) [Dimensions: 70x60.8x50 cm]
Multidose Vial Policy
WHO recommends that opened vials of this vaccine may be kept for use in subsequent immunization sessions (up to a maximum of 28 days) provided the conditions outlined in the WHO Policy Statement: The use of opened multi-dose vials of vaccine in subsequent immunization sessions are met.
Vaccine Preservative
none
Cold Chain Volume
0.49 cm3/dose (in secondary packaging)

Attachments

Package Insert